These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1512795)

  • 41. The incidence of cutaneous melanoma on Crete, Greece.
    Lasithiotakis K; Krüger-Krasagakis S; Manousaki A; Ioannidou D; Panagiotides I; Tosca A
    Int J Dermatol; 2006 Apr; 45(4):397-401. PubMed ID: 16650166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
    Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
    Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure.
    Elwood JM; Gallagher RP
    Int J Cancer; 1998 Oct; 78(3):276-80. PubMed ID: 9766557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of in Situ vs Invasive Melanoma: Testing the "Obligate Precursor" Hypothesis.
    Olsen CM; Pandeya N; Rosenberg PS; Whiteman DC
    J Natl Cancer Inst; 2022 Oct; 114(10):1364-1370. PubMed ID: 36042554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sun Protection and Skin Examination Practices in a Setting of High Ambient Solar Radiation: A Population-Based Cohort Study.
    Olsen CM; Thompson BS; Green AC; Neale RE; Whiteman DC;
    JAMA Dermatol; 2015 Sep; 151(9):982-90. PubMed ID: 26039788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spatial analysis of incidence of cutaneous melanoma in the Friuli Venezia Giulia region in the period 1995-2005.
    Cecconi L; Busolin A; Barbone F; Serraino D; Chiarugi A; Biggeri A; Catelan D
    Geospat Health; 2016 Apr; 11(1):422. PubMed ID: 27087039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous malignant melanoma in South Australia: the main features.
    Robertson I; Cook MG; Dymock RB; Orell SR
    Med J Aust; 1981 Jul; 2(2):92-4. PubMed ID: 7300715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011.
    Bay C; Kejs AM; Storm HH; Engholm G
    Cancer Epidemiol; 2015 Feb; 39(1):1-7. PubMed ID: 25468643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.
    Baxter AJ; Hughes MC; Kvaskoff M; Siskind V; Shekar S; Aitken JF; Green AC; Duffy DL; Hayward NK; Martin NG; Whiteman DC
    Twin Res Hum Genet; 2008 Apr; 11(2):183-96. PubMed ID: 18361720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective study of measured body size and height and risk of keratinocyte cancers and melanoma.
    Lahmann PH; Hughes MC; Williams GM; Green AC
    Cancer Epidemiol; 2016 Feb; 40():119-25. PubMed ID: 26707237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world.
    Jones WO; Harman CR; Ng AK; Shaw JH
    World J Surg; 1999 Jul; 23(7):732-5. PubMed ID: 10390596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Where the sun never shines: anorectal melanoma.
    Miller BJ; Rutherford LF; McLeod GR; Cohen JR
    Aust N Z J Surg; 1997 Dec; 67(12):846-8. PubMed ID: 9451338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.
    Robsahm TE; Bergva G; Hestvik UE; Møller B
    Melanoma Res; 2013 Feb; 23(1):70-8. PubMed ID: 23222548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extremely high levels of melanoma in Tauranga, New Zealand: possible causes and comparisons with Australia and the northern hemisphere.
    Salmon PJ; Chan WC; Griffin J; McKenzie R; Rademaker M
    Australas J Dermatol; 2007 Nov; 48(4):208-16. PubMed ID: 17956477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.
    Baade P; Meng X; Youlden D; Aitken J; Youl P
    Int J Cancer; 2012 Jan; 130(1):170-8. PubMed ID: 21344376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutaneous melanoma in New Zealand: 2000-2004.
    Liang JJ; Robinson E; Martin RC
    ANZ J Surg; 2010 May; 80(5):312-6. PubMed ID: 20557503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
    Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
    Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
    Downing A; Yu XQ; Newton-Bishop J; Forman D
    Int J Cancer; 2008 Aug; 123(4):861-6. PubMed ID: 18500743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden, 1968-1992.
    Thörn M; Pontén F; Johansson AM; Bergström R
    Cancer Detect Prev; 1998; 22(5):430-7. PubMed ID: 9727624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.